Meyron

Reference summary — not medical advice or a personal risk estimate.

Pioglitazone

Group 2A — probably carcinogenicMedications & MedicalchemicalEvidence: limited_in_humans

Summary

Classified by IARC as Group 2A — probably carcinogenic to humans. (Vol 108, 2016)

Regional relevance

global

global

Sources

Consumer references

Third-party tools some readers use alongside primary evidence. Meyron doesn't endorse them; we link them because you'll otherwise hit them anyway.